Showing results (681-690 of 738) with videos related to

Sort By:
Pageof 74
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2016
Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and InfectionLin Zhang, William K K Wu, Richard L Gallo, et al.
Briefings in Bioinformatics|March 30, 2021
Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistanceDan Huang, Xiansong Wang, Yingzhi Liu, et al.
Haematologica|April 18, 2020
Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet functionMelissa V Chan, Melissa A Hayman, Suthesh Sivapalaratnam, et al.
Anaesthesia|June 10, 2020
Risks to healthcare workers following tracheal intubation of patients with COVID-19: a prospective international multicentre cohort studyK El-Boghdadly, D J N Wong, R Owen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 6, 2019
Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trialAmit X Garg, Matthew T V Chan, Meaghan S Cuerden, et al.
JAMA Surgery|January 15, 2025
Safety and Efficacy of Tranexamic Acid in General SurgeryLily J Park, Maura Marcucci, Sandra N Ofori, et al.
Emerging Infectious Diseases|September 21, 2017
Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014Jeffery Ho, Rudin Z W Dai, Thomas N Y Kwong, et al.
Critical Care (London, England)|February 12, 2020
Cathelicidin preserves intestinal barrier function in polymicrobial sepsisJeffery Ho, Hung Chan, Yonghao Liang, et al.
Autophagy|January 8, 2019
Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cellsWei Hu, Lin Zhang, Ming Xing Li, et al.
The British Journal of Surgery|July 19, 2018
Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2)B M Biccard, A Sigamani, M T V Chan, et al.
Pageof 74